Browse our collection of papers in
Astrazeneca (AZN)
C/F/560. Strategic Financial Analysis of AstraZeneca and GlaxoSmithKline
- WORDS:
- 3100
- DATE:
- 2009
- PRICE:
- 39.99 GBP
The paper examines the factors that affected the financial performance of AstraZeneca (AZN) and GlaxoSmithKline (GSK) giving particular focus to the analysis of the product portfolio and recent developments in the pharmaceutical industry. An overview of the companies’ ratios over 2004-2008 is provided suggesting recommendations for the investors.
KEYWORDS: GlaxoSmithKline, GSK, AstraZeneca, AZN, pharmaceutical industry,
Other Papers On: Astrazeneca (AZN)
Other Papers On: GlaxoSmithKline (GSK)
Other Papers On: Financial Analysis
Other Papers On: Pharmaceutical Industry
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
Keywords Tag Cloud
astrazeneca swot pestel strategic value financial chain forces porter plc competitive evaluation glaxosmithkline c astra zeneca share strategy position performance movements valuation ubs price examination job market current opportunities environment graduate hr force ab company merger dissertation behaviour mba pharmaceutical azn converter sales digital study feasibility organisational
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
The quality of papers on this site is very good and the reference lists are extremely handy.Kevin
